Diabetic ketoacidosis in patients with type 2 diabetes: Risk factors for mortality and adverse outcomes

doi:10.5493/wjem.v16.i1.117464

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (66)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-6)

Sum=55

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=6

Mar 20, 2026 (publication date) through Mar 20, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Exp Med. Mar 20, 2026; 16(1): 117464
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.117464

Open in New Tab Full Size Figure Download Figure

Figure 1 The STROBE diagram of study selection. DKA: Diabetic ketoacidosis; T2DM: Type 2 diabetes mellitus; LOS: Length of stay; IQR: Interquartile range.

Citation: Chandrabalan V, Howcroft T, Alkhalifah MK, Younis N, Aldhafiri E, Pappachan JM. Diabetic ketoacidosis in patients with type 2 diabetes: Risk factors for mortality and adverse outcomes. World J Exp Med 2026; 16(1): 117464
URL: https://www.wjgnet.com/2220-315x/full/v16/i1/117464.htm
DOI: https://dx.doi.org/10.5493/wjem.v16.i1.117464